Expression of MUC16/CA125 Is Associated with Impaired Survival in Patients with Surgically Resected Cholangiocarcinoma.

Cancers (Basel) · 2022 · PMC9563928 · PMID 36230626

Europe PMC DOI

hedged sentence

0.3170

closest p · 6.3× alpha

0.3170

boldest claim

The sentences

did not reach statistical significancep = 0.317not close (p > 0.1)

Correspondingly, MUC16 (+) is associated with impaired OS rates in patients with dCCA (26.6 months (95% CI = 10–43.2)) in contrast to MUC16 (−) patients (52.7 (95% CI = 19.9–85.4)) although these results did not reach statistical significance ( p = 0.317) ( Figure 3 D).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.